|
Code
|
8387C
|
|
MA number
|
19/0212/18-S
|
|
Product Form:
|
tbl slg 56x1x2 mg/0,5 mg (blis.OPA/Al/PVC/Al - jednodáv.bal.)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Decentralised
|
|
MAH, country:
|
G.L. Pharma GmbH, Austria
|
|
Therapeutic Class:
|
19 - ANTIDOTA, DETOXICANTIA
|
|
ATC:
|
| N |
NERVOUS SYSTEM |
| N07 |
OTHER NERVOUS SYSTEM DRUGS |
| N07B |
DRUGS USED IN ADDICTIVE DISORDERS |
| N07BC |
Drugs used in opioid dependence |
| N07BC51 |
Buprenorphine, combinations |
|
|
Shelf life:
|
36 |
|
Container:
|
blister OPA/Al/PVC/Al
|
|
Route of admin.:
|
Sublingual use
|
PIL_Bupensanduou sublingvalne tablety_03_2025.pdf
